CD4 and cancer: Briefly, the median age was 54 years old (IQR 47, 59); all HIV patients were on ART at time of third dose, 92.6% had HIV-RNA < 50 copies/mL with a median time since HIV diagnosis of 7 years (3–12) and of 5 years (2–8) since AIDS, if diagnosed; 6.9% with a diagnosis of cancer; the three groups significantly differed for CD4 count nadir (p = 0.007), previous AIDS diagnosis (p < 0.001), time since AIDS diagnosis (p = 0.001), HIV-RNA (p < 0.001) at third dose.